The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ
Open accessAbstract
Adult T cell leukemia (ATL) is an aggressive malignancy secondary to chronic infection by the human T-cell leukemia virus type 1 (HTLV-1) infection. Two viral proteins, Tax and HBZ, play central roles in ATL leukemogenesis. Tax expression transforms T cells in vitro and induces ATL-like disease in mice. Tax also induces a rough eye phenotype and increases hemocyte count in Drosophila melanogaster, indicative of transformation. Among multiple functions, Tax modulates the expression of the enhancer of zeste homolog 2 (EZH2), a methyltransferase of the Polycomb Repressive Complex 2 (PRC2), leading to H3K27me3-dependent reprogramming of around half of cellular genes. HBZ is a negative regulator of Tax-mediated viral transcription. HBZ effects on epigenetic signatures are underexplored. Here, we established an hbz transgenic fly model, and demonstrated that, unlike Tax, which induces NF-κB activation and enhanced PRC2 activity creating an activation loop, HBZ neither induces transformation nor NF-κB activation in vivo. However, overexpression of Tax or HBZ increases the PRC2 activity and both proteins directly interact with PRC2 complex core components. Importantly, overexpression of HBZ in tax transgenic flies prevents Tax-induced NF-κB or PRC2 activation and totally rescues Tax-induced transformation and senescence. Our results establish the in vivo antagonistic effect of HBZ on Tax-induced transformation and cellular effects. This study helps understanding long-term HTLV-1 persistence and cellular transformation and opens perspectives for new therapeutic strategies targeting the epigenetic machinery in ATL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tax modulates expression of NF-κB and enhancer Polycomb Repressive Complex 2 (PRC2), which governs persistence and cellular transformation.
“Tax was shown to modulate the expression of NF-κB and the enhancer Polycomb Repressive Complex 2 (PRC2), which governs persistence and cellular transformation.”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [157]
The Results section reports that Tax activates NF-κB, enhances PRC2 activity, and induces transformation that depends on NF-κB and partly on PRC2. The Discussion links persistent infection to HBZ alleviating Tax’s deleterious effects; it does not show that Tax’s modulation of NF-κB and PRC2 governs persistence. No page numbers are available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredOverexpression of Hbz prevents Tax-induced NF-κB and PRC2 activation.
“Overexpression of Hbz was observed to prevent Tax-induced NF-κB and PRC2 activation, shedding light on the co-modulatory interplay of Tax and Hbz [157].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553
Drosophila innate immunity: an evolutionary perspective
Hoffmann, J. A., & Reichhart, J. (2002) · Nature Immunology · doi:10.1038/ni0202-121 · Cited by 1,168
Genome Regulation by Polycomb and Trithorax: 70 Years and Counting
Schuettengruber, B., Bourbon, H.-M., Di Croce, L., & Cavalli, G. (2017) · Cell · doi:10.1016/j.cell.2017.08.002 · Cited by 1,094
Reiterative Use of the EGF Receptor Triggers Differentiation of All Cell Types in the Drosophila Eye
Freeman, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81385-9 · Cited by 877
Integrated molecular analysis of adult T cell leukemia/lymphoma
Kataoka, K., Nagata, Y., Kitanaka, A., Shiraishi, Y., Shimamura, T., Yasunaga, J., Totoki, Y., Chiba, K., Sato‐Otsubo, A., Nagae, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3415 · Cited by 840
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Poiesz, B. J., Ruscetti, F. W., Reitz, M. S., Kalyanaraman, V. S., & Gallo, R. C. (1981) · Nature · doi:10.1038/294268a0 · Cited by 756
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells
Satou, Y., Yasunaga, J., Yoshida, M., & Matsuoka, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507631103 · Cited by 594
Hinuma, Y., Komoda, H., Chosa, T., Kondo, T., Kohakura, M., Takenaka, T., Kikuchi, M., Ichimaru, M., Yunoki, K., Satō, I., et al. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290606 · Cited by 589
The tat Gene of Human T-Lymphotropic Virus Type 1 Induces Mesenchymal Tumors in Transgenic Mice
Nerenberg, M., Hinrichs, S. H., Reynolds, R. K., Khoury, G., & Jay, G. (1987) · Science · doi:10.1126/science.2888190 · Cited by 510
Gaudray, G., Gachon, F., Basbous, J., Biard‐Piechaczyk, M., Devaux, C. A., & Mesnard, J.-M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12813-12822.2002 · Cited by 504
Multiple Viral Strategies of HTLV-1 for Dysregulation of Cell Growth Control
Yoshida, M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.475 · Cited by 455
Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.
Tanaka, A., Takahashi, C., Yamaoka, S., Nosaka, T., Maki, M., & Hatanaka, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1071 · Cited by 446
Evans, C. J., Hartenstein, V., & Banerjee, U. K. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00335-6 · Cited by 436
Murphy, E. L., Hanchard, B., Figueroa, J. P., Gibbs, W. N., Lofters, W., Campbell, M., Goedert, J. J., & Blattner, W. A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430214 · Cited by 403
Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato‐Otsubo, A., Muto, S., Utsunomiya, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.015 · Cited by 325
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319
Circulating Immune Cells Mediate a Systemic RNAi-Based Adaptive Antiviral Response in Drosophila
Tassetto, M., Kunitomi, M., & Andino, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.033 · Cited by 292
Marked for death: Targeting epigenetic changes in cancer
Pfister, S. X., & Ashworth, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.256 · Cited by 288
Hasegawa, H., Sawa, H., Lewis, M. J., Orba, Y., Sheehy, N., Yamamoto, Y., Ichinohe, T., Tsunetsugu‐Yokota, Y., Katano, H., Takahashi, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1389 · Cited by 282
Kinoshita, T., Shimoyama, M., Tobinai, K., Ito, M., Ito, S., Ikeda, S., Tajima, K., Shimotohno, K., & Sügimura, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5620 · Cited by 280
Yamano, Y., Nagai, M., Brennan, M. B., Mora, C. A., Soldan, S. S., Tomaru, U., Takenouchi, N., Izumo, S., Osame, M., & Jacobson, S. (2002) · Blood · doi:10.1182/blood.v99.1.88 · Cited by 277
Matsuoka, M., & Jeang, K.-T. (2010) · Oncogene · doi:10.1038/onc.2010.537 · Cited by 277
NF- B in the Immune Response of DrosophilaPreprint
Hétru, C., & Hoffmann, J. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000232 · Cited by 252
Targeting EZH2 in cancer therapy
Yamagishi, M., & Uchimaru, K. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000390 · Cited by 232
Basbous, J., André‐Arpin, C., Gaudray, G., Piechaczyk, M., Devaux, C. A., & Mesnard, J.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307275200 · Cited by 214
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
Arnold, J., Zimmerman, B., Li, M., Lairmore, M. D., & Green, P. L. (2008) · Blood · doi:10.1182/blood-2008-04-154286 · Cited by 207
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB
Zhao, T., Yasunaga, J., Satou, Y., Nakao, M., Takahashi, M., Fujii, M., & Matsuoka, M. (2008) · Blood · doi:10.1182/blood-2008-06-161729 · Cited by 199
Sun, S., & Ballard, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203220 · Cited by 189
Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response
Marriott, S. J., & Semmes, O. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208976 · Cited by 188
Saito, M., Matsuzaki, T., Satou, Y., Yasunaga, J.-I., Saito, K., Arimura, K., Matsuoka, M., & Ohara, Y. (2009) · Retrovirology · doi:10.1186/1742-4690-6-19 · Cited by 184
Mahgoub, M., Yasunaga, J., Iwami, S., Nakaoka, S., Koizumi, Y., Shimura, K., & Matsuoka, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715724115 · Cited by 184
Polycomb-dependent epigenetic landscape in adult T-cell leukemia
Fujikawa, D., Nakagawa, S., Hori, M., Kurokawa, N., Soejima, A., Nakano, K., Yamochi, T., Nakashima, M., Kobayashi, S., Tanaka, Y., et al. (2016) · Blood · doi:10.1182/blood-2015-08-662593 · Cited by 176
Clerc, I., Polakowski, N. J., André-Arpin, C., Cook, P. R., Barbeau, B., Mesnard, J.-M., & Lemasson, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803116200 · Cited by 171
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma—A Tale of Two Proteins: Tax and HBZ
Giam, C., & Semmes, O. J. (2016) · Viruses · doi:10.3390/v8060161 · Cited by 171
Franchini, G., Wong‐Staal, F., & Gallo, R. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.6207 · Cited by 156
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis
Ma, G., Yasunaga, J., & Matsuoka, M. (2016) · Retrovirology · doi:10.1186/s12977-016-0249-x · Cited by 150
Zhi, H., Yang, L., Kuo, Y.-L., Ho, Y.-K., Shih, H.-M., & Giam, C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002025 · Cited by 143
HBZ interacts with JunD and stimulates its transcriptional activity
Thébault, S., Basbous, J., Hivin, P., Devaux, C. A., & Mesnard, J.-M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00225-x · Cited by 143
Sasaki, D., Imaizumi, Y., Hasegawa, H., Osaka, A., Tsukasaki, K., Choi, Y. L., Mano, H., Márquez, V. E., Hayashi, T., Yanagihara, K., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.028605 · Cited by 104
Billman, M. R., Rueda, D., & Bangham, C. R. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12469.1 · Cited by 102
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
Hajj, H. E., El-Sabban, M. E., Hasegawa, H., Zaatari, G. S., Ablain, J., Saab, S. T., Janin, A., Mahfouz, R. A., Nasr, R., Kfoury, Y. S., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101095 · Cited by 98
Self-citationPortis, T., Harding, J. C., & Ratner, L. (2001) · Blood · doi:10.1182/blood.v98.4.1200 · Cited by 93
Activation of the anaphase promoting complex by HTLV‐1 tax leads to senescence
Kuo, Y., & Giam, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601054 · Cited by 93
Gessain, A., Louie, A. T., Gout, O., Gallo, R. C., & Franchini, G. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1628-1633.1991 · Cited by 93
Genetic alterations in adult T‐cell leukemia/lymphoma
Kogure, Y., & Kataoka, K. (2017) · Cancer Science · doi:10.1111/cas.13303 · Cited by 91
Goon, P. K. C., Biancardi, A., Fast, N. M., Igakura, T., Hanon, E., Mosley, A. J., Asquith, B., Gould, K. G., Marshall, S. E., Taylor, G. P., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/420832 · Cited by 88
Tanaka, A., Yasunaga, J., Takai, K., & Matsuoka, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0436 · Cited by 86
Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B.
KANNO, T., Brown, K., Franzoso, G., & Siebenlist, U. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6443 · Cited by 86
ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation
Dassouki, Z., Şahin, U., Hajj, H. E., Jollivet, F., Kfoury, Y. S., Lallemand-Breitenbach, V., Hermine, O., de Thé, H., & Bazarbachi, A. A. (2014) · Blood · doi:10.1182/blood-2014-04-572750 · Cited by 84
Self-citationHoutz, P., Bonfini, A., Liu, X., Revah, J., Guillou, A., Poidevin, M., Hens, K., Huang, H., Deplancke, B., Tsai, Y.-C., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007091 · Cited by 84
Human T-cell leukaemia virus type 1: parasitism and pathogenesis
Bangham, C. R. M., & Matsuoka, M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0272 · Cited by 83
The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells
Ohsugi, T., Kumasaka, T., Okada, S., & Urano, T. (2007) · Nature Medicine · doi:10.1038/nm0507-527 · Cited by 79
Banerjee, P., Feuer, G., & Barker, E. (2007) · Journal of Virology · doi:10.1128/jvi.00887-07 · Cited by 79
Nakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79
HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role
Fochi, S., Mutascio, S., Bertazzoni, U., Zipeto, D., & Romanelli, M. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00285 · Cited by 67
Mechanisms of Persistent NF‐κB Activation by HTLV‐I Tax
Harhaj, E. W., & Harhaj, N. S. (2005) · IUBMB Life · doi:10.1080/15216540500078715 · Cited by 48
Mesnard, J.-M., Barbeau, B., Césaire, R., & Péloponèse, J. (2015) · Viruses · doi:10.3390/v7122952 · Cited by 42
Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-κB pathway
Kfoury, Y., Nasr, R., Hermine, O., de Thé, H., & Bazarbachi, A. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401624 · Cited by 40
Self-citationPanfil, A. R., Dissinger, N. J., Howard, C. M., Murphy, B. M., Landes, K., Fernandez, S. A., & Green, P. L. (2016) · Journal of Virology · doi:10.1128/jvi.03113-15 · Cited by 39
Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice
Zhao, T., Satou, Y., & Matsuoka, M. (2014) · Archives of Virology · doi:10.1007/s00705-014-2099-y · Cited by 35
Nasr, R., Hajj, H. E., Kfoury, Y. S., de Thé, H., Hermine, O., & Bazarbachi, A. A. (2011) · Viruses · doi:10.3390/v3060750 · Cited by 35
Self-citationShirinian, M., Kambris, Z., Hamadeh, L., Grabbe, C., Journo, C., Mahieux, R., & Bazarbachi, A. (2015) · Journal of Virology · doi:10.1128/jvi.00918-15 · Cited by 29
Self-citationHTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
Xiang, J., Rauch, D. A., Huey, D. D., Panfil, A. R., Cheng, X., Esser, A. K., Su, X., Harding, J. C., Xu, Y., Fox, G. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128713 · Cited by 19
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
Esser, A. K., Rauch, D. A., Xiang, J., Harding, J. C., Kohart, N. A., Ross, M. H., Su, X., Wu, K. G., Huey, D. D., Xu, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20565 · Cited by 18
Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence
Shudofsky, A. D., & Giam, C. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018029322 · Cited by 16
Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.
Wang, W., Wang, F., Zong, G.-Q., Liu, R., Zhang, Y., Luan, Y., Xu, L., & Xuan, J. (2015) · PubMed · Cited by 14
Alasiri, A., Guerr, J. A., Hall, W. W., & Sheehy, N. (2019) · Journal of Virology · doi:10.1128/jvi.00412-19 · Cited by 11
Outa, A. A., Abubaker, D., Bazarbachi, A. A., El-Sabban, M. E., Shirinian, M., & Nasr, R. (2019) · Haematologica · doi:10.3324/haematol.2019.219394 · Cited by 10
Self-citationMouse Models That Enhanced Our Understanding of Adult T Cell Leukemia
Moodad, S., Akkouche, A., Hleihel, R., Darwiche, N., El-Sabban, M. E., Bazarbachi, A. A., & Hajj, H. E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00558 · Cited by 8
Self-citationMolecular mechanisms of apoptosis suppression by HTLV-1 bZIP factor in HTLV-1 infected cells
Tanaka, A., Yasunaga, J., Takai, K., & Matsuoka, M. (2014) · Retrovirology · doi:10.1186/1742-4690-11-s1-o51 · Cited by 2
Flagged first, then by citations
Cited by
Sorted by citations
Viral oncogenesis in cancer: from mechanisms to therapeutics
Xiao, Q., Liu, Y., Li, T., Wang, C., He, S., Zhai, L., Yang, Z., Zhang, X., Wu, Y., & Liu, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02197-9 · Cited by 106
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
Forlani, G., Shallak, M., Accolla, R. S., & Romanelli, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158001 · Cited by 53
Pathogenesis of HTLV-1 infection and progression biomarkers: An overview
Brites, C. R., Grassi, M. F. R., Quaresma, J. A. S., Ishak, R., & Vallinoto, A. C. R. (2021) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2021.101594 · Cited by 44
Regulation of HTLV-1 transformation
Ernzen, K. J., & Panfil, A. R. (2022) · Bioscience Reports · doi:10.1042/bsr20211921 · Cited by 39
Hleihel, R., Skayneh, H., de Thé, H., Hermine, O., & Bazarbachi, A. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00841-7 · Cited by 31
Self-citationHTLV‐1 persistent infection and ATLL oncogenesis
Zuo, X., Zhou, R., Yang, S., & Ma, G. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28424 · Cited by 34
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities
Hleihel, R., Akkouche, A., Skayneh, H., Hermine, O., Bazarbachi, A. A., & Hajj, H. E. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01138-3 · Cited by 24
Self-citationHajj, H. E., & Bazarbachi, A. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957535 · Cited by 27
Self-citationCurrent State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“The cessation of therapy in HIV is associated with a strong viral rebound to pre-therapeutic plasma viral loads [164–166] and may be similarly mimicked in the incidence of successful treatment of HTLV-1 with ART.”
BackgroundToyoda, K., Yasunaga, J., Shichijo, T., Arima, Y., Tsujita, K., Tanaka, A., Salah, T., Zhang, W., Hussein, O., Sonoda, M., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0139 · Cited by 23
HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation
Bellon, M., & Nicot, C. (2024) · Pathogens · doi:10.3390/pathogens13010087 · Cited by 17
Marino‐Merlo, F., Grelli, S., Mastino, A., Lai, M., Ferrari, P., Nicolini, A., Pistello, M., & Macchi, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914807 · Cited by 16
Miller, R., Zimmer, A., Moutot, G., Mesnard, J.-M., & Chazal, N. (2021) · Viruses · doi:10.3390/v13112221 · Cited by 11
Therapeutic advances for the management of adult T cell leukemia: Where do we stand?
Hajj, H. E., Hermine, O., & Bazarbachi, A. A. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107598 · Cited by 6
Self-citationDuchateau, T., Afonso, P. V., & Journo, C. (2025) · Journal of Virology · doi:10.1128/jvi.00601-25 · Cited by 6
CRISPR Targeting the Integrated HTLV-1 Virus
Wilkie, T., & Panfil, A. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_6 · Cited by 3
Mohammedsaleh, Z. M., & Shater, A. F. (2026) · Reviews in Medical Virology · doi:10.1002/rmv.70162 · Cited by 1
Nuñez, K., Fuentes-Montoya, J. G., Enciso, L. J., Jairo Jaime, C., & Corredor-Figueroa, A. P. (2026) · Viruses · doi:10.3390/v18030342
Modulation de la fonctionnalité des cellules dendritiques humaines par le rétrovirus HTLV-1
Carcone, A. (2023) · theses.fr (ABES) · doi:10.70675/7c8dfa21z0138z4187zb4e3z1e6596bfbedc
HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next‐Generation Therapies
Mohammad-Rezaei, M., Shafaghat, Z., Noroozbeygi, M., Baig, M. R., jasim, R. A., Smerat, A., Fakhri, F., Safari, E., & Jafari, R. (2026) · Leukemia Research · doi:10.1016/j.leukres.2026.108326
Metadata
- Authors
- Akkouche, A., Moodad, S., Hleihel, R., Skayneh, H., Chambeyron, S., El Hajj, H., & Bazarbachi, A.
- Affiliations
- American University of Beirut (LB)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Bazarbachi, Ali
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-01-20
- Volume
- 17
- Issue
- 1
- Pages
- e1009219
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC7817025
- OpenAlex
- W3124694565
- Cited by
- 20
- References
- 73
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 4
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American University of Beirut
- Lady Tata Memorial Trust
- National Institutes of Health (NIH P40OD018537, P40OD018537)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- HTLV-1, taxation, HBZ, adult T-cell leukemia/lymphoma, cell transformation, polycomb repressive complex 2, EZH2, H3K27me3, NF-κB, epigenetic reprogramming, Drosophila melanogaster, senescence, viral transcription regulation
- MeSH terms
- Animals, Drosophila melanogaster, HeLa Cells, Humans, Retroviridae Proteins, Human T-lymphotropic virus 1, HTLV-I Infections, Gene Expression Regulation, Viral, Gene Products, tax, Cellular Senescence, Basic-Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review